Impact of Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist on Outcomes Following Major Surgery

Documenti analoghi

• Surgical outcomes and healthcare expenditures among patients with dementia undergoing major surgery
  di: Mujtaba Khalil, et al.
  Pubblicazione: (2024)
• Association of county‐level provider density with hepatobiliary cancer incidence and mortality
  di: Muhammad Muntazir Mehdi Khan, et al.
  Pubblicazione: (2024)
• Neoadjuvant Glucagon‐Like Peptide‐1 Receptor Agonists in Abdominal Wall Hernia Surgery: A Narrative Review
  di: Swetha Prabhakaran, et al.
  Pubblicazione: (2026)
• Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist Treatment to Allow Safe Laparoscopic Left Pancreatectomy in Extreme Obesity: The First Report
  di: Giulia Canali, et al.
  Pubblicazione: (2026)
• Impact of GLP ‐ 1RA on the Risk of Adverse Liver Outcomes Among Patients With Alcohol‐Associated Liver Disease and Type 2 Diabetes
  di: Zayed Rashid, et al.
  Pubblicazione: (2024)